Bard Associates Inc Invitae Corp Transaction History

Bard Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$7.54 - $18.31 $482,469 - $1.17 Million	-63,988 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$4.87 - $8.42 $29,512 - $51,025	-6,060 Reduced 8.65%	63,988 $470,000
Q1 2018 May 14, 2018	SELL	$4.69 - $10.05 $18,928 - $40,561	-4,036 Reduced 5.45%	70,048 $329,000
Q4 2017 Feb 13, 2018	BUY	$7.86 - $9.99 $582,300 - $740,099	74,084	74,084 $673,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.